Drug-Drug Interaction Study of Atumelnant in Healthy Participants
Clinical trial NCT07570082 · COMPLETED
Trial details
- NCT number
- NCT07570082
- Sponsor
- Crinetics Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-28
- Primary completion
- 2026-06-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.